A Novel Angiotensin Type I Receptor Antagonist, Fimasartan, Prevents Doxorubicin-induced Cardiotoxicity in Rats

Angiotensin receptor blockers (ARBs) have organ-protective effects in heart failure and may be also effective in doxorubicin-induced cardiomyopathy (DOX-CMP); however, the efficacy of ARBs on the prevention of DOX-CMP have not been investigated. We performed a preclinical experiment to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Sung-A, Lim, Byung-Kwan, Lee, You Jung, Hong, Mi-Kyung, Choi, Jin-Oh, Jeon, Eun-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414639/
https://www.ncbi.nlm.nih.gov/pubmed/25931786
http://dx.doi.org/10.3346/jkms.2015.30.5.559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414639/
https://www.ncbi.nlm.nih.gov/pubmed/25931786
http://dx.doi.org/10.3346/jkms.2015.30.5.559

Ejemplares similares